Volpara Health Technologies Marge brute
Quel est le Marge brute de Volpara Health Technologies?
Le Marge brute de Volpara Health Technologies Limited est 92.46%
Quelle est la définition de Marge brute?
La marge brute est la différence entre le revenu et le coût des biens vendus, divisée par le revenu et exprimée en pourcentage.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Marge brute des entreprises dans Health Care secteur sur ASX par rapport à Volpara Health Technologies
Que fait Volpara Health Technologies?
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry worldwide. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback; Volpara Lung, a patient management software; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients' risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. Volpara Health Technologies Limited has a strategic relationship with RevealDx to enhance lung screening capabilities. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was incorporated in 2009 and is headquartered in Wellington, New Zealand.
Entreprises avec marge brute similaire à Volpara Health Technologies
- Future Market Networks a Marge brute de 92.38%
- Assura Plc a Marge brute de 92.40%
- Corporacion Financiera Alba, S.A a Marge brute de 92.43%
- Neoen S.A a Marge brute de 92.43%
- China International Capital a Marge brute de 92.44%
- Schroder British Opportunities Ltd a Marge brute de 92.45%
- Volpara Health Technologies a Marge brute de 92.46%
- Elanor Commercial Property Fund a Marge brute de 92.48%
- Lineage Cell Therapeutics Inc a Marge brute de 92.50%
- Dorchester Minerals LP a Marge brute de 92.55%
- Vastned Retail NV a Marge brute de 92.57%
- OneMain Inc a Marge brute de 92.61%
- MAS Services a Marge brute de 92.62%